Topics

Human medicines European public assessment report (EPAR): Galafold, migalastat, Fabry Disease, Date of authorisation: 25/05/2016, Revision: 9, Status: Authorised

07:10 EDT 29 Apr 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Galafold, migalastat, Fabry Disease, Date of authorisation: 25/05/2016, Revision: 9, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Galafold, migalastat, Fabry Disease, Date of authorisation: 25/05/2016, Revision: 9, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Galafold, migalastat, Fabry Disease, Date of authorisation: 25/05/2016, Revision: 9, Status: Authorised"

Quick Search